Month: April 2020

Copenhagen, 8 April 2020                                   The Annual General Meeting of EAC Invest A/S will take place on Thursday 30 April 2020 at 14.00 pm at East Asiatic House, Indiakaj 16, 2100 Copenhagen Ø.Please find attached the notice including agenda and exhibit.COVID-19The injunctions and regulation adopted in connection with the COVID-19 pandemic, including restrictions on public gatherings, are expected to have consequences on the conducting of the upcoming annual general meeting in EAC Invest A/S. The Company has, however, decided to convene and hold the annual general meeting on 30 April 2020, as originally planned. The general meeting will be held in accordance with the applicable rules and guidelines issued by public authorities. Furthermore, the Company will take any step necessary to ensure the health and security of...

København, 8. april 2020                                     Den ordinære generalforsamling i EAC Invest A/S vil blive afholdt torsdag den 30. april 2020 kl. 14:00 i East Asiatic House, Indiakaj 16, 2100 København Ø.Vedhæftet dagsorden med bilag.COVID-19De påbud og regler, der er fastsat i forbindelse med COVID-19-pandemien, herunder begrænsninger i offentlige samlinger, forventes at få konsekvenser for afviklingen af EAC Invest A/S’ kommende ordinære generalforsamling. Selskabet har dog besluttet at indkalde til og afvikle den ordinære generalforsamling den 30. april 2020, som oprindeligt planlagt. Generalforsamlingen vil blive afholdt i overensstemmelse med de regler og anbefalinger fra myndighederne, der gælder på tidspunktet for generalforsamlingen. Selskabet vil derudover tage de skridt, som selskabet finder nødvendige for at sikre...

ORLANDO, Fla., April 08, 2020 (GLOBE NEWSWIRE) — As government and private institutions race to develop an effective cure for patients infected by COVID-19, two antimalarial drugs–chloroquine and hydroxychloroquine–have shown some possible potential. Under an emergency use authorization (“EUA”), the FDA has authorized these antimalarial drugs to be distributed and prescribed by doctors to COVID-19 patients, as appropriate, when a clinical trial is not available or feasible. Though both drugs are still in their testing phases.Chloroquine and hydroxychloroquine pose cardiac risks. And so managing those risks during the treatment process is key to the successful implementation. In a recent press release, Biotricity (OTC: BTCY), a medical diagnostic and consumer healthcare technology company, announced that its premier product...

CALGARY, Alberta, April 08, 2020 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (the “Corporation” or “CEMATRIX”), a North American leading manufacturer and supplier of technologically advanced cellular concrete products, would like to provide a business update related to the impact of COVID-19, as mentioned in its news release dated March 26, 2020.  While the situation continues to be extremely fluid, CEMATRIX projects, including those of its subsidiaries, CEMATRIX (Canada) Inc. (“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout Company (“PIGCO”) continue to move forward as scheduled.  The COVID-19 virus could still impact CEMATRIX or its operating subsidiaries in some way, but as of today, the Corporation has rectified its short-term cash flow needs and is pouring product in several locations daily...

FALLS CHURCH, Va., April 08, 2020 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) plans to release its first quarter 2020 financial results on Wednesday, April 29, 2020. You are invited to participate in a conference call following this release. The information is:A live audio broadcast of the conference call will be available on the Investor Relations page of the Northrop Grumman website at http://www.northropgrumman.com.For those who cannot participate in this call, it will be archived on the Investor Relations page for a limited time. It will also be recorded and available through Thursday, May. 7, 2020, by calling 1-855-859-2056 (domestic) or 1-404-537-3406 (international).  Please use conference ID 9447018.If you have any questions, please call Todd Ernst, corporate vice president and treasurer, vice president Investor...

ELECTRA GRUPPEN AB (publ) orgnr. 556065-4054

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — In response to queries related to an internal bulletin sent out to TELUS employees on Monday, April 6, TELUS is confirming that CEO Darren Entwistle will forgo his salary for the 3 months of April, May and June 2020, and donate it to Canadian healthcare workers on the front lines, battling COVID-19.In addition, The Entwistle Family Foundation, established in 2018 by Darren and his wife Fiona, will match this donation, stemming from the 100 per cent salary reduction, in order to double the positive financial impact for health caregivers and, by extension, those vulnerable citizens who need assistance the most. Through this donation, Darren is privileged to demonstrate his deep admiration for everything the TELUS team has done to support healthcare in Canada.About TELUSTELUS...

VANCOUVER, Colombie-Britannique, 08 avr. 2020 (GLOBE NEWSWIRE) — En réponse à des commentaires reçus suite à l’envoi d’une communication interne destinée aux membres de l’équipe de TELUS le lundi 6 avril, TELUS confirme que le chef de la direction de l’entreprise, Darren Entwistle, renonce à son salaire pour les mois d’avril, de mai et de juin 2020, et le remet aux travailleurs de la santé canadiens qui sont aux premières lignes pour lutter contre la COVID-19.De plus, la Fondation de la famille Entwistle, créée en 2018 par Darren et son épouse Fiona, égale le don lié à la réduction de 100 pour cent de salaire, ce qui permet de doubler l’impact financier positif en appui aux soignants ainsi qu’aux personnes les plus vulnérables qui ont besoin de soutien. Par l’entremise de ce don, Darren se sent privilégié de pouvoir démontrer son...

On 30 April 2020 the ordinary General Meeting of Shareholders of Snaigė AB, the address of head office Pramonės str. 6, Alytus, the company code 249664610 (hereinafter, the “Company”) is convened the ordinary General Meeting of Shareholders (hereinafter, the “Meeting”). The place of the meeting –at AB “Snaige” office, at the address Kareiviu str. 6, Vilnius, Lithuania. The Meeting commences – at 10 a.m. (registration starts at 9.45 a.m.).If the quarantine announced in the territory of the Republic of Lithuania by Government Resolution No. 207 of 14 March 2020 will be continuing on the meeting day, the meeting will not take place on meeting place but the Company’s shareholders are invited to participate in the ordinary General meeting and vote on the agenda items in writing, by filling voting ballot in advance and submitting to the...

2020 m. balandžio 30 d. šaukiamas AB „Snaigė“, buveinės adresas Pramonės g. 6, Alytus, įmonės kodas 249664610 (toliau – Bendrovė) eilinis visuotinis akcininkų susirinkimas (toliau – Susirinkimas).                Susirinkimo vieta – AB „Snaigė“  ofisas, Kareivių g. 6 (5 aukštas), Vilnius.                Susirinkimo pradžia – 10:00 val. (registracija prasidės 9:45 val.).Susirinkimo dieną tęsiantis, 2020 m. kovo 14 d. Lietuvos Respublikos Vyriausybės nutarimu Nr. 207 Lietuvos Respublikos teritorijoje paskelbtam karantinui,  posėdis susirinkimo vietoje nebus rengiamas, o Bendrovės akcininkai kviečiami dalyvauti eiliniame visuotiniame akcininkų susirinkime  ir balsuoti susirinkimo dienotvarkės klausimais iš anksto pateikiant Bendrovei tinkamai užpildytus bendruosius balsavimo biuletenius.                Susirinkimo apskaitos diena – 2020 m....